Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 6, Issue 11

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 6, Issue 11 (1997)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 6, Issue 11 (1997)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Volume 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Review Article

The therapeutic potential of novel anticoagulants

Liguo Chi, Karen L Rogers, Andrew CG Uprichard & Kim P. Gallagher

Pages: 1591-1605

Published online: 23 Feb 2005

AbstractforThe therapeutic potential of novel anticoagulants | References | PDF (303.4 KB)

42 Views
11 CrossRef citations
0Altmetric

Review Article

Overview of clinical trials with glycoprotein IIb-IIIa receptor antagonists in the prevention and management of coronary

Bernhard R Winkelmann, Ralf Zahn & Hans Ulrich Stilz

Pages: 1623-1642

Published online: 23 Feb 2005

AbstractforOverview of clinical trials with glycoprotein IIb-IIIa receptor antagonists in the prevention and management of coronary | References | PDF (162.2 KB)

12 Views
1 CrossRef citations
0Altmetric

Review Article

The role of the renin angiotensin system in chronic renal disease

Salah D Kivlighn & David J Dzielak

Pages: 1643-1650

Published online: 23 Feb 2005

AbstractforThe role of the renin angiotensin system in chronic renal disease | References | PDF (77.3 KB)

21 Views
0 CrossRef citations
0Altmetric

Review Article

The antiatherogenic potential of blocking the renin-angiotensin system

Regina M Goetz

Pages: 1651-1658

Published online: 23 Feb 2005

AbstractforThe antiatherogenic potential of blocking the renin-angiotensin system | References | PDF (86.2 KB)

9 Views
1 CrossRef citations
0Altmetric

Review Article

Recent advances in the development of haemoglobin-based blood substitutes

Anil Gulati

Pages: 1659-1669

Published online: 23 Feb 2005

AbstractforRecent advances in the development of haemoglobin-based blood substitutes | References | PDF (120.7 KB)

22 Views
4 CrossRef citations
0Altmetric

Miscellaneous

Growth factor antagonists for the treatment of diabetic vascular complications

Ronald G Tilton, Richard AF Dixon & Tommy A Brock

Pages: 1671-1684

Published online: 23 Feb 2005

AbstractforGrowth factor antagonists for the treatment of diabetic vascular complications | References | PDF (124 KB)

39 Views
4 CrossRef citations
0Altmetric

Gene therapy for haemophilia

Theodore AG Smith

Pages: 1685-1690

Published online: 23 Feb 2005

AbstractforGene therapy for haemophilia | References | PDF (65 KB)

14 Views
4 CrossRef citations
0Altmetric

New prospects for cardiovascular gene therapy

Carmel M Lynch

Pages: 1691-1696

Published online: 23 Feb 2005

AbstractforNew prospects for cardiovascular gene therapy | References | PDF (74.8 KB)

11 Views
0 CrossRef citations
0Altmetric

Novelties in the field of macrolides

André Bryskier

Pages: 1697-1709

Published online: 23 Feb 2005

AbstractforNovelties in the field of macrolides | References | PDF (183.5 KB)

24 Views
15 CrossRef citations
0Altmetric

Anticancer activity of farnesyltransferase and geranylgeranyltransferase i inhibitors: prospects for drug development

Saïd M Sebti & Andrew D Hamilton

Pages: 1711-1714

Published online: 23 Feb 2005

AbstractforAnticancer activity of farnesyltransferase and geranylgeranyltransferase i inhibitors: prospects for drug development | References | PDF (54 KB)

28 Views
10 CrossRef citations
0Altmetric

Antigen-specific therapies for the treatment of multiple sclerosis: a clinical trial update

Edward G Spack

Pages: 1715-1727

Published online: 23 Feb 2005

AbstractforAntigen-specific therapies for the treatment of multiple sclerosis: a clinical trial update | References | PDF (131.1 KB)

42 Views
4 CrossRef citations
0Altmetric

Drug Evaluation

Article

Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychotic

John M Kane & Carol A Tamminga

Pages: 1729-1741

Published online: 23 Feb 2005

AbstractforSertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychotic | References | PDF (132 KB)

37 Views
17 CrossRef citations
0Altmetric

Article

Olanzapine (Zyprexa):charactirestics of a new antipsychotic

Carol A Tamminga & John M Kane

Pages: 1743-1752

Published online: 23 Feb 2005

AbstractforOlanzapine (Zyprexa):charactirestics of a new antipsychotic | References | PDF (98 KB)

100 Views
14 CrossRef citations
0Altmetric

Meeting Report

10th International Conference on Antiviral Research

Roger J Brideau

Pages: 1753-1756

Published online: 23 Feb 2005

Abstractfor10th International Conference on Antiviral Research | PDF (45.7 KB)

18 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.6, Iss.11, 1997)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?